These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23866809)

  • 1. Reduction of microglial activity in a model of multiple sclerosis by dipyridamole.
    Sloka S; Metz LM; Hader W; Starreveld Y; Yong VW
    J Neuroinflammation; 2013 Jul; 10():89. PubMed ID: 23866809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis.
    Bao Z; Hao J; Li Y; Feng F
    Mol Med Rep; 2019 Dec; 20(6):5190-5196. PubMed ID: 31702807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
    Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
    J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced microglial phagocytosis in multiple sclerosis and experimental autoimmune encephalomyelitis and the underlying mechanisms.
    Ju WY; Wang Q; Song LJ; Ding ZB; Li XH; Kumar G; Yan Y; Ma CG
    Mol Biol Rep; 2023 Jan; 50(1):749-759. PubMed ID: 36309614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
    Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ
    Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate.
    Miljković D; Blaževski J; Petković F; Djedović N; Momčilović M; Stanisavljević S; Jevtić B; Mostarica Stojković M; Spasojević I
    J Immunol; 2015 Mar; 194(6):2493-503. PubMed ID: 25681336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
    Koch MW; Zabad R; Giuliani F; Hader W; Lewkonia R; Metz L; Wee Yong V
    J Neurol Sci; 2015 Nov; 358(1-2):131-7. PubMed ID: 26344560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
    Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM
    Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
    Bhasin M; Wu M; Tsirka SE
    BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
    Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
    Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
    Martín R; Hernández M; Córdova C; Nieto ML
    Br J Pharmacol; 2012 Jul; 166(5):1708-23. PubMed ID: 22260389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
    Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.
    van Loo G; Sze M; Bougarne N; Praet J; Mc Guire C; Ullrich A; Haegeman G; Prinz M; Beyaert R; De Bosscher K
    Mol Endocrinol; 2010 Feb; 24(2):310-22. PubMed ID: 19965930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.